15 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →
| FY | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| 2025 | $2M | -$23M | 0.0% | -1258.5% | -$20M | $7M | $1M |
| 2024 | $1M | -$27M | 0.0% | -2190.9% | -$26M | $5M | $3M |
| 2023 | $775302 | -$36M | 0.0% | -4641.8% | -$19M | $5M | $21M |
| 2022 | $306392 | -$31M | 0.0% | -10372.4% | -$17M | $4M | $11M |
| 2021 | $90035 | -$27M | 0.0% | -31469.0% | -$22M | $3M | $21M |
| 2021 | — | $122M | — | — | — | $3M | $28M |
| 2021 | — | -$116M | — | — | — | $3M | — |
| 2020 | $13433 | -$20M | 0.0% | -158176.2% | -$18M | $3M | $19M |
| 2020 | — | -$96M | — | — | — | $3M | — |
| 2019 | $17096 | -$16M | 0.0% | -93840.2% | -$13M | $3M | — |
| 2019 | — | -$86M | — | — | — | $2M | — |
| 2019 | — | -$82M | — | — | — | $3M | — |
| 2019 | — | -$78M | — | — | — | $2M | — |
| 2018 | — | -$18M | — | — | -$14M | $3M | — |
| 2018 | — | -$69M | — | — | — | $2M | — |
| Quarter | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| Mar '26 | $985076 | -$7M | 0.0% | -543.0% | -$5M | $7M | $3M |
| Dec '25 | $447034 | -$6M | 0.0% | -1077.9% | -$6M | $7M | $1M |
| Sep '25 | $627277 | -$5M | 0.0% | -813.2% | -$4M | $6M | $199407 |
| Jun '25 | $406688 | -$6M | 0.0% | -1548.6% | -$6M | $7M | $2M |
| Mar '25 | $246385 | -$5M | 0.0% | -2241.1% | -$4M | $6M | $3M |
| Dec '24 | $191657 | -$6M | 0.0% | -3016.5% | -$6M | $5M | $3M |
| Sep '24 | $474522 | -$6M | 0.0% | -1236.8% | -$6M | $5M | $5M |
| Jun '24 | $395797 | -$7M | 0.0% | -1766.2% | -$7M | $5M | $6M |
| Mar '24 | $171535 | -$8M | 0.0% | -4887.9% | -$8M | $5M | $12M |
| Dec '23 | $243973 | -$9M | 0.0% | -3582.6% | $6M | $5M | $21M |
| Sep '23 | $165211 | -$8M | 0.0% | -5237.6% | -$9M | $3M | $11M |
| Jun '23 | $216310 | -$10M | 0.0% | -4414.5% | -$8M | $4M | $20M |
| Mar '23 | $149808 | -$9M | 0.0% | -6037.7% | -$9M | $4M | $10M |
| Dec '22 | $119715 | -$7M | 0.0% | -6691.4% | -$6M | $4M | $11M |
| Sep '22 | $32714 | -$8M | 0.0% | -24432.8% | -$7M | $3M | $16M |
| Jun '22 | $39752 | -$8M | 0.0% | -20375.0% | -$7M | $3M | $17M |
| Mar '22 | $114211 | -$8M | 0.0% | -6721.7% | $3M | $3M | $24M |
| Dec '21 | $14240 | -$8M | 0.0% | -61692.6% | -$5M | $3M | $21M |
| Sep '21 | $25483 | -$7M | 0.0% | -29675.8% | -$5M | $3M | $23M |
| Jun '21 | $24782 | -$6M | 0.0% | -23810.3% | -$6M | $3M | $28M |
How the market has priced VNRX against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.
Over the past 5 years, VOLITIONRX LTD's revenue has grown 164.1% per year. These are computed facts, not advice.
As of FY2025, VOLITIONRX LTD reported $7M of total debt against $1M of cash.
In FY2025, gross margin was —, operating margin -1258.5%, and net margin -1352.2%.
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.